Top 20 holders own 49% from memory. So they'll be in favour of low dilution too. This can rocket back up on a hint of good news given the low volumes that are generally available.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025